DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: In that study, six dystrophinopathy carriers were identified at a carrier rate of 1:4088, but the identified DMD variants did not include the exon 49–51 deletion (Han et al., 2020).